Visiongain Publishes Pre-Filled Syringes Market Report 2024-2034
The global Pre-Filled Syringes market is estimated at US$5,069.3 million in 2024 and is expected to register a CAGR of 9.5% from 2024 to 2034.
Healthcare & Pharma
Visiongain Publishes Generic Drugs Market Report 2024-2034
The global Generic Drugs market is estimated at US$450.7 billion in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period 2024-2034.
Visiongain Publishes Pharma Wholesale and Distribution Market Report 2024-2034
The global Pharma Wholesale and Distribution market is estimated at US$844.2 billion in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period 2024-2034.
Visiongain Publishes Biobanking Market Report 2024-2034
The global Biobanking market is estimated at US$75.4 billion in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period 2024-2034.
Visiongain Publishes Dermatological Drugs Market Report 2024-2034
The Dermatological Drugs market is estimated at US$30.47 billion in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period 2024-2034.
Visiongain Publishes Allergic Rhinitis Drugs Market Report 2024-2034
The global Allergic Rhinitis Drugs market is estimated at US$16,821.6 million in 2024 and is expected to register a CAGR of 2.7% from 2024 to 2034.
Visiongain Publishes Translational Regenerative Medicine Market Report 2024-2034
The global Translational Regenerative Medicine market is estimated at US$77.93 billion in 2024 and is expected to register a CAGR of 24.3% from 2024 to 2034.
Visiongain Publishes Epilepsy Therapeutics Market Report 2024-2034
The global Epilepsy Therapeutics market is estimated at US$9,858.7 million in 2024 and is projected to grow at a CAGR of 8.1% during the forecast period 2024-2034.
Visiongain Publishes Companion Diagnostics (CDx) Market Report 2024-2034
The global Companion Diagnostics (CDx) market is estimated at US$6,574.6 million in 2024 and is projected to grow at a CAGR of 11% during the forecast period 2024-2034.
Neuromodulation Devices Market Report 2024-2034, Overview of Visiongain’s 251 page report.
The global Neuromodulation Devices market is estimated at US$10,002.7 million in 2024 and is expected to register a CAGR of 12.4% from 2024 to 2034.
Visiongain Publishes Respiratory Drug Delivery Market Report 2024-2034
The global Respiratory Drug Delivery market is estimated at US$67.11 billion in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period 2024-2034.
Visiongain Publishes Pharmaceutical Logistics Market Report 2024-2034
The global Pharmaceutical Logistics Market is estimated at US$93.3 billion in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period 2024-2034.
Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2024-2034
The precision cancer diagnostic test market was valued at US$10,623.3 million in 2023 and is projected to grow at a CAGR of 16.1% during the forecast period 2024-2034.
Antibacterial Drugs Market Report 2024-2034
The Antibacterial Drug market was valued at US$ 39,178.7 million in 2024 and is projected to grow at a CAGR of 3.6% during the forecast period 2024-2034.
Visiongain Publishes Pharma Clinical Trial Services Market Report 2024-2034
The global Pharma Clinical Trial Services market was valued at US$40.91 billion in 2023 and is projected to grow at a CAGR of 8.6% during the forecast period 2024-2034.
Visiongain Publishes Cell-Based Assays Market Report 2024-2034
The global Cell-Based Assays market is estimated at US$18,875.2 million in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period 2024-2034.
Visiongain Publishes Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034
The global Viral Vectors and Plasmid DNA Manufacturing market is estimated at US$1,168.9 million in 2023 and is projected to grow at a CAGR of 17.5% during the forecast period 2024-2034.
Visiongain Publishes Biological Drug API Manufacturing Services Market Report 2023-2033
The global Biological Drug API Manufacturing Services market is valued at US$8,006.7 million in 2023 and is projected to grow at a CAGR of 11.6% during the forecast period 2023-2033.
Visiongain Publishes Bioprocess Validation Market Report 2023-2033
The global Bioprocess Validation market is estimated at US$498.5 million in 2023 and is projected to grow at a CAGR of 10.8% during the forecast period 2023-2033.
Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2024-2034
The global OTC Drugs & Dietary Supplements market was valued at US$ 211.8 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
